PA GOODDOCTOR1833.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, PA GOODDOCTOR (1833.HK) trades at a P/E of 23.40x, P/B of 1.07x, P/S of 1.99x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 1st percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/B sits at the 12th percentile over the trailing 10Y window (vs. 29th percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 5th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 80th percentile within its industry and the 78th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B long-window percentiles differ by only 10.4 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. PA GOODDOCTOR operates in the Industrial Internet sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1833 · SEHK: 1833 · 1833
Want the full picture on whether PA GOODDOCTOR (1833.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 23.40 | ||||||
| P/B (MRQ) | 1.07 | ||||||
| P/S (TTM) | 1.99 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |